University of Maryland, Baltimore: Prostatic Neoplasms trials

The registry lists 13 Prostatic Neoplasms studies with University of Maryland, Baltimore as lead sponsor. 1 are open to participants now and 1 have results posted.

Phase 1 3Phase 2 8No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• TERPS Trial for de Novo Oligometastic Prostate CancerRecruitingNCT05223803Phase 2
• Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance ImagingTerminatedNCT04698564Phase 2Results posted
• High-Risk Metachronous Oligometastatic Prostate Cancer TrialActive, not recruitingNCT06212583Phase 2
• Towards Understanding Between ADT Treatment, Circadian Rhythm, and Physiological ResponsivenessActive, not recruitingNCT05968144Phase 1/2
• Hypofractionated Accelerated Pelvic Nodal Radiotherapy (GCC 2048)Active, not recruitingNCT04486755Phase 1
• Ketogenic Diet and Prostate Cancer Surveillance PilotCompletedNCT03194516
• Prostate Cancer SurveyCompletedNCT03128710
• Focal Therapy for Prostate CancerWithdrawnNCT01802307Phase 2
• Improving Cancer Foci Detection in Prostate Cancer Using Multiparametric MRI/MRSWithdrawnNCT01766869
• Vaccine Therapy in Treating Patients With Recurrent Prostate CancerCompletedNCT00030602Phase 2
• Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate CancerCompletedNCT00005028Phase 2
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate CancerCompletedNCT00003400Phase 2
• Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid TumorsCompletedNCT00002677Phase 1